Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.

A combination of immunotherapy and targeted cancer treatment given before and after surgery may reduce the risk of recurrence and improve survival in ...

Accelerated water-bath thawing, completed in about 25 minutes, may help streamline clinical workflows and support efficient patient management -- Label update includes data showing that product ...

Ferring Pharmaceuticals’ Adstiladrin receives US FDA label update to speed up thaw time: Parsippany, New Jersey Friday, March 27, 2026, 12:00 Hrs [IST] Ferring Pharmaceuticals a ...

Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company’s lead development ...

Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...

In A Nutshell A common blood pressure drug, telmisartan, boosted the effectiveness of a cancer drug in lab and mouse studies.

Cancer is not an outside invader but a biological process, explains Dr. Alexandra Drakaki, medical director of the ...

Like around 60,000 women in the UK each year, Dawn underwent a hysteroscopy in May 2023 - a procedure to look inside the womb ...

Scientists are using proteomics to decode the complex biology of endometriosis, revealing protein patterns that could enable earlier, non-invasive diagnosis and more personalized care.

Diagnostic test based on urinary tumor markers hold promise for earlier or prompt detection of bladder cancer in patients ...